Loading ARWR charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading ARWR comparable companies…
| ARWRArrowhead Pharmaceuticals, Inc.(opens in a new tab) | $8.59B | $0.67B | +16.8% | — | −33.8% | 12.83× | — |
|---|---|---|---|---|---|---|---|
| NRIXNurix Therapeutics, Inc.(opens in a new tab) | $3.11B | $0.70B | +738.8% | — | 41.3% | 4.43× | 11.6× |
| RAREUltragenyx Pharmaceutical Inc.(opens in a new tab) | $1.64B | $0.72B | +17.5% | 97.2% | −73.6% | 2.29× | — |
| MIRMMirum Pharmaceuticals, Inc.(opens in a new tab) | $5.38B | $0.62B | +44.0% | — | −134.9% | 8.71× | — |
| AMPHAmphastar Pharmaceuticals, Inc.(opens in a new tab) | $1.23B | $0.73B | +1.0% | 47.7% | 15.7% | 1.68× | 16.4× |
| Medianpeers, excl. ARWR | $2.38B | $0.71B | +30.8% | 72.4% | −29.0% | 3.36× | 14.0× |